150 related articles for article (PubMed ID: 3866691)
21. Inhibition of VIP-stimulated ion transport by a novel Y-receptor phenotype in rabbit distal colon.
Ballantyne GH; Goldenring JR; Fleming FX; Rush S; Flint JS; Fielding LP; Binder HJ; Modlin IM
Am J Physiol; 1993 May; 264(5 Pt 1):G848-54. PubMed ID: 8388641
[TBL] [Abstract][Full Text] [Related]
22. Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y.
Bischoff A; Avramidis P; Erdbrügger W; Münter K; Michel MC
Br J Pharmacol; 1997 Apr; 120(7):1335-43. PubMed ID: 9105710
[TBL] [Abstract][Full Text] [Related]
23. Insulin secretion in rats: effects of neuropeptide Y and noradrenaline.
Pettersson M; Ahrén B
Diabetes Res; 1990 Jan; 13(1):35-42. PubMed ID: 2097094
[TBL] [Abstract][Full Text] [Related]
24. Effects of peptide YY and its analogues on chloride ion secretion in fed and fasted rat jejunum.
Eto B; Boisset M; Eden P; Balasubramaniam A; Desjeux JF
Peptides; 1995; 16(8):1403-9. PubMed ID: 8745050
[TBL] [Abstract][Full Text] [Related]
25. Neuropeptide Y antagonises secretagogue evoked chloride transport in rat jejunal epithelium.
Cox HM; Cuthbert AW
Pflugers Arch; 1988 Nov; 413(1):38-42. PubMed ID: 2464161
[TBL] [Abstract][Full Text] [Related]
26. NPY Y2 receptor agonist PYY(3-36) inhibits diarrhea by reducing intestinal fluid secretion and slowing colonic transit in mice.
Moriya R; Shirakura T; Hirose H; Kanno T; Suzuki J; Kanatani A
Peptides; 2010 Apr; 31(4):671-5. PubMed ID: 19925840
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the antisecretory effect of endogenous forms of peptide YY on fed and fasted rat jejunum.
Eto B; Boisset M; Anini Y; Voisin T; Desjeux JF
Peptides; 1997; 18(8):1249-55. PubMed ID: 9396069
[TBL] [Abstract][Full Text] [Related]
28. Prostaglandin-mediated action of sennosides.
Beubler E; Kollar G
Pharmacology; 1988; 36 Suppl 1():85-91. PubMed ID: 3163424
[TBL] [Abstract][Full Text] [Related]
29. Characterization of Y3 receptor-mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem.
Glaum SR; Miller RJ; Rhim H; Maclean D; Georgic LM; MacKenzie RG; Grundemar L
Br J Pharmacol; 1997 Feb; 120(3):481-7. PubMed ID: 9031753
[TBL] [Abstract][Full Text] [Related]
30. Neuropeptide Y: a powerful modulator of epithelial ion transport.
Friel DD; Miller RJ; Walker MW
Br J Pharmacol; 1986 Jun; 88(2):425-31. PubMed ID: 3755365
[TBL] [Abstract][Full Text] [Related]
31. Y2 receptors for peptide YY and neuropeptide Y on dispersed chief cells from guinea pig stomach.
Singh G; Singh L; Raufman JP
Am J Physiol; 1992 Apr; 262(4 Pt 1):G756-62. PubMed ID: 1314499
[TBL] [Abstract][Full Text] [Related]
32. Peptide YY is a physiological regulator of water and electrolyte absorption in the canine small bowel in vivo.
Bilchik AJ; Hines OJ; Adrian TE; McFadden DW; Berger JJ; Zinner MJ; Ashley SW
Gastroenterology; 1993 Nov; 105(5):1441-8. PubMed ID: 8224646
[TBL] [Abstract][Full Text] [Related]
33. Actions of neuropeptide Y on basal, cyclic AMP-induced and neurally evoked ion transport in porcine distal jejunum.
Brown DR; Boster SL; Overend MF; Parsons AM; Treder BG
Regul Pept; 1990 Jun; 29(1):31-47. PubMed ID: 2167504
[TBL] [Abstract][Full Text] [Related]
34. Peptide histidine isoleucine: a secretagogue in human jejunum.
Anagnostides AA; Christofides ND; Tatemoto K; Chadwick VS; Bloom SR
Gut; 1984 Apr; 25(4):381-5. PubMed ID: 6546731
[TBL] [Abstract][Full Text] [Related]
35. Effects of peptide YY on the human cardiovascular system: reversal of responses to vasoactive intestinal peptide.
Playford RJ; Benito-Orfila MA; Nihoyannopoulos P; Nandha KA; Cockcroft J; Todd S; Ghatei MA; Domin J; Bloom SR; Calam J
Am J Physiol; 1992 Oct; 263(4 Pt 1):E740-7. PubMed ID: 1415694
[TBL] [Abstract][Full Text] [Related]
36. PYY-preferring receptor in the dorsal vagal complex and its involvement in PYY stimulation of gastric acid secretion in rats.
Yang H; Li WP; Reeve JR; Rivier J; Taché Y
Br J Pharmacol; 1998 Apr; 123(8):1549-54. PubMed ID: 9605560
[TBL] [Abstract][Full Text] [Related]
37. Effect of fourth ventricular neuropeptide Y and peptide YY on ingestive and other behaviors.
Corp ES; Melville LD; Greenberg D; Gibbs J; Smith GP
Am J Physiol; 1990 Aug; 259(2 Pt 2):R317-23. PubMed ID: 2386243
[TBL] [Abstract][Full Text] [Related]
38. Neuropeptide Y, peptide YY and C-terminal fragments release histamine from rat peritoneal mast cells.
Grundemar L; Håkanson R
Br J Pharmacol; 1991 Dec; 104(4):776-8. PubMed ID: 1725763
[TBL] [Abstract][Full Text] [Related]
39. Effects of neuropeptide Y, peptide YY and sigma ligands on ion transport in mouse jejunum.
Riviere PJ; Rao RK; Pascaud X; Junien JL; Porreca F
J Pharmacol Exp Ther; 1993 Mar; 264(3):1268-74. PubMed ID: 8450462
[TBL] [Abstract][Full Text] [Related]
40. Peptide YY antagonizes beta-adrenergic-stimulated release of insulin in dogs.
Greeley GH; Lluis F; Gomez G; Ishizuka J; Holland B; Thompson JC
Am J Physiol; 1988 Apr; 254(4 Pt 1):E513-7. PubMed ID: 2895586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
